Chromatin remodeling factor lymphoid-specific helicase links with Epstein-Barr virus associated the follicular germinal center B cell lymphomas

Journal of Cancer Research and Therapeutics

Volumn 15, Issue 2, 2019, Pages 350-357

  Ouyang, Chunhui ^a   Deng, Zhenghao ^b   Zhou, Jianhua ^b   Fu, Chunyan ^b   Liu, Shuang ^c   Tao, Yongguang ^d   Xiao, Desheng ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 hmC; B cell lymphomas; E2F1; germinal center; lymphoid specific helicase

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; HELICASE; KI 67 ANTIGEN; TRANSCRIPTION FACTOR E2F1; BIOLOGICAL MARKER; DNA HELICASE; HELLS PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIFFUSE LARGE B CELL LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE; MARGINAL ZONE LYMPHOMA; PHENOTYPE; STAINING; B CELL LYMPHOMA; COMPLICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; PATHOLOGY; VIROLOGY;

BIOMARKERS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIAGNOSIS, DIFFERENTIAL; DNA HELICASES; EPSTEIN-BARR VIRUS INFECTIONS; GERMINAL CENTER; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL;

EID: 85063970833     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/jcrt.JCRT-243-18     Document Type: Article

References (30)

1. De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol 2015;15:137-48.
2. Xu Y, Zhou X, Li Y, Zhang Y, Wang X. Expression and clinical significance of centrosomal protein 55 in T-cell lymphoma. J Cancer Res Ther 2018;14:94-8.
3. Hatzi K, Melnick A. Breaking bad in the germinal center: How deregulation of BCL6 contributes to lymphomagenesis. Trends Mol Med 2014;20:343-52.
4. Shaffer AL 3rd, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol 2012;30:565-610.
5. Koues OI, Kowalewski RA, Chang LW, Pyfrom SC, Schmidt JA, Luo H, et al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma. Immunity 2015;42:186-98.
6. Koues OI, Oltz EM, Payton JE. Short-circuiting gene regulatory networks: Origins of B cell lymphoma. Trends Genet 2015;31:720-31.
7. Kulis M, Merkel A, Heath S, Queirós AC, Schuyler RP, Castellano G, et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet 2015;47:746-56.
8. Matsuda I, Imai Y, Hirota S. Global histone modification profiles are well conserved between normal B lymphocytes and neoplastic counterparts. Pathol Oncol Res 2010;16:447-51.
9. Peters SL, Hlady RA, Opavska J, Klinkebiel D, Pirruccello SJ, Talmon GA, et al. Tumor suppressor functions of dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis. Leukemia 2014;28:1138-42.
10. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009;360:2289-301.
11. Xiao D, Shi Y, Fu C, Jia J, Pan Y, Jiang Y, et al. Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas. Leuk Res 2016;42:75-9.
12. Scourzic L, Couronné L, Pedersen MT, Della Valle V, Diop M, Mylonas E, et al. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice. Leukemia 2016;30:1388-98.
13. Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, Figueroa ME, et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011;118:3559-69.
14. Dominguez PM, Teater M, Chambwe N, Kormaksson M, Redmond D, Ishii J, et al. DNA methylation dynamics of germinal center B cells are mediated by AID. Cell Rep 2015;12:2086-98.
15. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011;11:481-92.
16. Myant K, Termanis A, Sundaram AY, Boe T, Li C, Merusi C, et al. LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res 2011;21:83-94.
17. Tao Y, Xi S, Shan J, Maunakea A, Che A, Briones V, et al. Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proc Natl Acad Sci U S A 2011;108:5626-31.
18. Yu W, McIntosh C, Lister R, Zhu I, Han Y, Ren J, et al. Genome-wide DNA methylation patterns in LSH mutant reveals de-repression of repeat elements and redundant epigenetic silencing pathways. Genome Res 2014;24:1613-23.
19. Zemach A, Kim MY, Hsieh PH, Coleman-Derr D, Eshed-Williams L, Thao K, et al. The arabidopsis nucleosome remodeler DDM1 allows DNA methyltransferases to access H1-containing heterochromatin. Cell 2013;153:193-205.
20. Burrage J, Termanis A, Geissner A, Myant K, Gordon K, Stancheva I. The SNF2 family ATPase LSH promotes phosphorylation of H2AX and efficient repair of DNA double-strand breaks in mammalian cells. J Cell Sci 2012;125:5524-34.
21. Keyes WM, Pecoraro M, Aranda V, Vernersson-Lindahl E, Li W, Vogel H, et al. δNp63α is an oncogene that targets chromatin remodeler lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 2011;8:164-76.
22. von Eyss B, Maaskola J, Memczak S, Möllmann K, Schuetz A, Loddenkemper C, et al. The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. EMBO J 2012;31:972-85.
23. Wang R, Shi Y, Chen L, Jiang Y, Mao C, Yan B, et al. The ratio of foxA1 to foxA2 in lung adenocarcinoma is regulated by lncRNA HOTAIR and chromatin remodeling factor LSH. Sci Rep 2015;5:17826.
24. Liu S, Tao YG. Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver. Chin J Cancer 2016;35:72.
25. Xiao D, Huang J, Pan Y, Li H, Fu C, Mao C, et al. Chromatin remodeling factor LSH is upregulated by the LRP6-GSK3β-E2F1 axis linking reversely with survival in gliomas. Theranostics 2017;7:132-43.
26. Wu H, Li W, Zhang M, Zhu S, Zhang D, Wang X, et al. Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1. J Cancer Res Ther 2016;12:68-71.
27. Xiao D, Jia J, Shi Y, Fu C, Chen L, Jiang Y, et al. Opposed expression of IKKα: Loss in keratinizing carcinomas and gain in non-keratinizing carcinomas. Oncotarget 2015;6:25499-505.
28. Khan H, Gupta S, Husain N, Misra S, Singh N, Negi MP, et al. Prognostics of cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. J Cancer Res Ther 2014;10:258-64.
29. He X, Yan B, Liu S, Jia J, Lai W, Xin X, et al. Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Res 2016;76:5743-55.
30. He Q, Zhou Y, Fu C, Zhu W, Zhou J, Liu S, et al. Lymphoepithelioma is a nonkeratinizing squamous cell carcinoma with Epstein-Barr virus infection in China. J Cancer Res Ther 2017;13:807-12.